Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank93
3Y CAGR-10.2%
5Y CAGR+27.9%
Year-over-Year Change
Income taxes paid or accrued
3Y CAGR
-10.2%/yr
vs +82.5%/yr prior
5Y CAGR
+27.9%/yr
Recent deceleration
Acceleration
-92.6pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
3.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $4.13M | +158.6% |
| 2024 | $1.60M | +187.5% |
| 2023 | $-1.82M | -132.0% |
| 2022 | $5.70M | +445.6% |
| 2021 | $1.04M | -13.5% |
| 2020 | $1.21M | -63.2% |
| 2019 | $3.28M | +538.7% |
| 2018 | $514000.00 | +103.2% |
| 2017 | $-16.20M | -46382.9% |
| 2016 | $35000.00 | - |